Menu
Recruiting NCT04107181

Pilot Study for Speculum Free Cervical Cancer Screening

No phase Interventional Cervical Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Introducer "calla" device, Interviews only.
Who it may be relevant to
Registry conditions: Cervical Cancer. Basic parameters: 21 years — 65 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Pilot Study Continuation to Assess the Use of an Introducer "Calla" During Cervical Cancer Screening

Overview

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Detailed description

This project is to assess if the introducer, "calla", can be used in place of a speculum during a routine Pap smear. For the patient arm, the introducer will be used in conjunction with standard of care procedures. The healthy volunteer arm will include taking the introducer home for a week to determine if each person can find their cervix without the help of a physician. As well as completing surveys on ease of use and demographics related to their medial history.

Interventions

  • Device Introducer "calla" device
    The research introducer will be used after the patient consents prior to the annual pap smear.
  • Behavioral Interviews only
    Healthy volunteer interviews

Primary outcome measures

  • Assessment of introducer [Time frame: Up to 1 week (at time of pap smear for patients and up to 1 week for healthy volunteers)]

Eligibility criteria

Inclusion criteria

Healthy female

  • Aged 21-65 years
  • Have had a pelvic exam
  • Have conversational proficiency in English
  • Highest level of education attained

Exclusion criteria

\- Pregnant women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Screening

Study locations

United States · 1 center
  • Duke University — Durham

Identifiers

NCT: NCT04107181 · Pro00008173_1 · R01CA239268-04

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗